Detection of SARS-CoV-2 IgG Targeting Nucleocapsid or Spike Protein by Four High-Throughput Immunoassays Authorized for Emergency Use

A total of 1,200 serum samples that were tested for SARS-CoV-2 IgG antibody using the Abbott Architect immunoassay targeting the nucleocapsid protein were run in 3 SARS-CoV-2 IgG immunoassays targeting spike proteins (DiaSorin Liaison, Ortho Vitros, and Euroimmun). Consensus-positive and consensus-n...

Descripción completa

Detalles Bibliográficos
Autores principales: Prince, Harry E., Givens, Tara S., Lapé-Nixon, Mary, Clarke, Nigel J., Schwab, Dale A., Batterman, Hollis J., Jones, Robert S., Meyer, William A., Kapoor, Hema, Rowland, Charles M., Haji-Sheikhi, Farnoosh, Marlowe, Elizabeth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Immunoassays
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587121/
https://www.ncbi.nlm.nih.gov/pubmed/32817144
http://dx.doi.org/10.1128/JCM.01742-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7587121/
https://www.ncbi.nlm.nih.gov/pubmed/32817144
http://dx.doi.org/10.1128/JCM.01742-20

Ejemplares similares